J. Braun1, Rosaline van den Berg2, Xenofon Baraliakos3, Heinrich Boehm4, Rubén Queiró5, Eduardo Collantes‐Estévez6, B. A. C. Dijkmans7, Paul Emery8, MA Khan9, K Pavelka10
1Rheumazentrum Ruhrgebiet, Landgrafenstrasse 15, 44652 Herne, Germany.
2Leiden University
3Rheumazentrum Ruhrgebiet St. Josefs-Krankenhaus
4Wirbelsaulenzentrum
5Universidad Nacional Autonoma de Mexico
6University of Cordoba, Instituto Maimónides de Investigacion Biomédica de Córdoba (IMIBC), Spain
7University of Amsterdam#N#
8University of Leeds
9Case Western Reserve University, Cleveland, Ohio, USA
10Charles University
Tóm tắt
This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature since 2005 and the discussion and agreement among 21 international experts, 2 patients and 2 physiotherapists in a meeting in February 2010. Each original bullet point was discussed in detail and reworded if necessary. Decisions on new recommendations were made — if necessary after voting. The strength of the recommendations (SOR) was scored on an 11-point numerical rating scale after the meeting by email. These recommendations apply to patients of all ages that fulfill the modified NY criteria for AS, independent of extra-articular manifestations, and they take into account all drug and non-drug interventions related to AS. Four overarching principles were introduced, implying that one bullet has been moved to this section. There are now 11 bullet points including 2 new ones, one related to extra-articular manifestations and one to changes in the disease course. With a mean score of 9.1 (range 8-10) the SOR was generally very good.
